arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.arformoterol and trazodone both increase QTc interval. Use Caution/Monitor.triamterenetriamterene increases and arformoterol decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.triazolamtriazolam increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.triclabendazolearformoterol and triclabendazole both increase QTc interval. Use Caution/Monitor.triclofostriclofos increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.trifluoperazinetrifluoperazine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.trimipraminetrimipramine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.arformoterol and trimipramine both increase QTc interval. Use Caution/Monitor.triprolidinetriprolidine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.triptorelintriptorelin increases toxicity of arformoterol by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes.valbenazinevalbenazine and arformoterol both increase QTc interval. Use Caution/Monitor.vandetanibarformoterol and vandetanib both increase QTc interval. Use Caution/Monitor.vardenafilarformoterol and vardenafil both increase QTc interval. Use Caution/Monitor.vemurafenibarformoterol and vemurafenib both increase QTc interval. Use Caution/Monitor.voclosporinvoclosporin, arformoterol. Either increases effects of the other by QTc interval. Use Caution/Monitor.voriconazolearformoterol and voriconazole both increase QTc interval. Use Caution/Monitor.vorinostatarformoterol and vorinostat both increase QTc interval. Use Caution/Monitor.xylometazolinearformoterol and xylometazoline both decrease sedation. Use Caution/Monitor.arformoterol and xylometazoline both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.yohimbinearformoterol and yohimbine both decrease sedation. Use Caution/Monitor.arformoterol and yohimbine both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.ziconotideziconotide increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.ziprasidoneziprasidone increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.arformoterol and ziprasidone both increase QTc interval. Use Caution/Monitor.Minor (15)bendroflumethiazidearformoterol, bendroflumethiazide. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Hypokalemia.bumetanidearformoterol, bumetanide. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Hypokalemia.chlorothiazidearformoterol, chlorothiazide. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Hypokalemia.chlorthalidonearformoterol, chlorthalidone. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Hypokalemia.cyclopenthiazidearformoterol, cyclopenthiazide. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Hypokalemia.ethacrynic acidarformoterol, ethacrynic acid. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Hypokalemia.eucalyptuseucalyptus increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.furosemidearformoterol, furosemide. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Hypokalemia.hydrochlorothiazidearformoterol, hydrochlorothiazide. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Hypokalemia.indapamidearformoterol, indapamide. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Hypokalemia.methyclothiazidearformoterol, methyclothiazide. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Hypokalemia.metolazonearformoterol, metolazone. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Hypokalemia.noni juicenoni juice increases and arformoterol decreases serum potassium. Effect of interaction is not clear, use caution. Minor/Significance Unknown.sagesage increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.torsemidearformoterol, torsemide. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Hypokalemia.acebutololMonitor Closely (2)acebutolol decreases effects of arformoterol by pharmacodynamic antagonism. Use Caution/Monitor. acebutolol increases and arformoterol decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.aceclofenacMonitor Closely (1)aceclofenac increases and arformoterol decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.acemetacinMonitor Closely (1)acemetacin increases and arformoterol decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.adagrasibSerious - Use Alternative (1)adagrasib, arformoterol. Either increases effects of the other by QTc interval. Avoid or Use Alternate Drug. Each drug prolongs the QTc interval, which may increased the risk of Torsade de pointes, other serious arryhthmias, and sudden death. If coadministration unavoidable, more frequent monitoring is recommended for such patients.albuterolMonitor Closely (3)albuterol and arformoterol both decrease serum potassium. Use Caution/Monitor. albuterol and arformoterol both decrease sedation. Use Caution/Monitor. albuterol and arformoterol both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.alfentanilMonitor Closely (1)alfentanil increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.alfuzosinMonitor Closely (2)arformoterol and alfuzosin both increase QTc interval. Use Caution/Monitor. alfuzosin and arformoterol both increase QTc interval. Use Caution/Monitor.alprazolamMonitor Closely (1)alprazolam increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.amilorideMonitor Closely (1)amiloride increases and arformoterol decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.amiodaroneMonitor Closely (1)arformoterol and amiodarone both increase QTc interval. Use Caution/Monitor.amisulprideSerious - Use Alternative (1)arformoterol and amisulpride both increase QTc interval. Avoid or Use Alternate Drug. ECG monitoring is recommended if coadministered.amitriptylineMonitor Closely (2)arformoterol and amitriptyline both increase QTc interval. Use Caution/Monitor. amitriptyline increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.Serious - Use Alternative (1)amitriptyline, arformoterol. Other (see comment). Avoid or Use Alternate Drug. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.amobarbitalMonitor Closely (1)amobarbital increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.amoxapineMonitor Closely (1)amoxapine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.Serious - Use Alternative (1)amoxapine, arformoterol. Other (see comment). Avoid or Use Alternate Drug. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.anagrelideMonitor Closely (1)arformoterol and anagrelide both increase QTc interval. Use Caution/Monitor.apomorphineMonitor Closely (1)apomorphine and arformoterol both increase QTc interval. Use Caution/Monitor.aripiprazoleMonitor Closely (2)aripiprazole increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor. aripiprazole and arformoterol both increase QTc interval. Use Caution/Monitor.armodafinilMonitor Closely (1)arformoterol and armodafinil both decrease sedation. Use Caution/Monitor.arsenic trioxideMonitor Closely (1)arformoterol and arsenic trioxide both increase QTc interval. Use Caution/Monitor.artemetherMonitor Closely (1)artemether and arformoterol both increase QTc interval. Use Caution/Monitor.artemether/lumefantrineMonitor Closely (1)arformoterol and artemether/lumefantrine both increase QTc interval. Use Caution/Monitor.asenapineMonitor Closely (1)arformoterol and asenapine both increase QTc interval. Use Caution/Monitor.asenapine transdermalMonitor Closely (1)asenapine transdermal and arformoterol both increase QTc interval. Use Caution/Monitor.aspirinMonitor Closely (1)aspirin increases and arformoterol decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.aspirin rectalMonitor Closely (1)aspirin rectal increases and arformoterol decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor. .aspirin/citric acid/sodium bicarbonateMonitor Closely (1)aspirin/citric acid/sodium bicarbonate increases and arformoterol decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.atenololMonitor Closely (2)atenolol decreases effects of arformoterol by pharmacodynamic antagonism. Use Caution/Monitor. atenolol increases and arformoterol decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.atomoxetineMonitor Closely (2)arformoterol, atomoxetine. Other (see comment). Use Caution/Monitor. Comment: Exercise caution if beta-agonists and atomoxetine are coadministered. Interaction may be less likely with inhaled beta-agonists versus those given systemically. . atomoxetine and arformoterol both increase QTc interval. Use Caution/Monitor.azelastineMonitor Closely (1)azelastine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.azithromycinMonitor Closely (1)azithromycin increases toxicity of arformoterol by QTc interval. Use Caution/Monitor.bedaquilineMonitor Closely (1)arformoterol and bedaquiline both increase QTc interval. Modify Therapy/Monitor Closely. ECG should be monitored closelybelladonna and opiumMonitor Closely (1)belladonna and opium increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.bendroflumethiazideMonitor Closely (1)arformoterol and bendroflumethiazide both decrease serum potassium. Use Caution/Monitor.Minor (1)arformoterol, bendroflumethiazide. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Hypokalemia.benperidolMonitor Closely (1)benperidol increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.benzphetamineMonitor Closely (2)arformoterol and benzphetamine both decrease sedation. Use Caution/Monitor. arformoterol and benzphetamine both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor.betaxololMonitor Closely (2)betaxolol decreases effects of arformoterol by pharmacodynamic antagonism. Use Caution/Monitor. betaxolol increases and arformoterol decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.bisoprololMonitor Closely (2)bisoprolol decreases effects of arformoterol by pharmacodynamic antagonism. Use Caution/Monitor. bisoprolol increases and arformoterol decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.brompheniramineMonitor Closely (1)brompheniramine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.bumetanideMonitor Closely (1)arformoterol and bumetanide both decrease serum potassium. Use Caution/Monitor.Minor (1)arformoterol, bumetanide. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Hypokalemia.buprenorphineMonitor Closely (1)arformoterol and buprenorphine both increase QTc interval. Use Caution/Monitor.buprenorphine buccalMonitor Closely (2)buprenorphine buccal increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor. buprenorphine buccal and arformoterol both increase QTc interval. Use Caution/Monitor.buprenorphine subdermal implantMonitor Closely (1)buprenorphine subdermal implant and arformoterol both increase QTc interval. Use Caution/Monitor.buprenorphine transdermalMonitor Closely (1)buprenorphine transdermal and arformoterol both increase QTc interval. Use Caution/Monitor.buprenorphine, long-acting injectionMonitor Closely (1)buprenorphine, long-acting injection and arformoterol both increase QTc interval. Use Caution/Monitor.butabarbitalMonitor Closely (1)butabarbital increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.butalbitalMonitor Closely (1)butalbital increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.butorphanolMonitor Closely (1)butorphanol increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.caffeineMonitor Closely (1)arformoterol and caffeine both decrease sedation. Use Caution/Monitor.carbenoxoloneMonitor Closely (1)arformoterol and carbenoxolone both decrease serum potassium. Use Caution/Monitor.carbinoxamineMonitor Closely (1)carbinoxamine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.carvedilolMonitor Closely (2)carvedilol decreases effects of arformoterol by pharmacodynamic antagonism. Use Caution/Monitor. carvedilol increases and arformoterol decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.celecoxibMonitor Closely (1)celecoxib increases and arformoterol decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.celiprololMonitor Closely (2)celiprolol decreases effects of arformoterol by pharmacodynamic antagonism. Use Caution/Monitor. celiprolol increases and arformoterol decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.ceritinibMonitor Closely (1)ceritinib and arformoterol both increase QTc interval. Use Caution/Monitor.chloral hydrateMonitor Closely (1)chloral hydrate increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.chlordiazepoxideMonitor Closely (1)chlordiazepoxide increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.chloroquineMonitor Closely (1)chloroquine increases toxicity of arformoterol by QTc interval. Use Caution/Monitor.chlorothiazideMonitor Closely (1)arformoterol and chlorothiazide both decrease serum potassium. Use Caution/Monitor.Minor (1)arformoterol, chlorothiazide. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Hypokalemia.chlorpheniramineMonitor Closely (1)chlorpheniramine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.chlorpromazineMonitor Closely (2)arformoterol and chlorpromazine both increase QTc interval. Use Caution/Monitor. chlorpromazine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.chlorthalidoneMonitor Closely (1)arformoterol and chlorthalidone both decrease serum potassium. Use Caution/Monitor.Minor (1)arformoterol, chlorthalidone. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Hypokalemia.choline magnesium trisalicylateMonitor Closely (1)choline magnesium trisalicylate increases and arformoterol decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor. .cinnarizineMonitor Closely (1)cinnarizine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.ciprofloxacinMonitor Closely (1)arformoterol and ciprofloxacin both increase QTc interval. Use Caution/Monitor.cisaprideContraindicated (1)arformoterol and cisapride both increase QTc interval. Contraindicated.citalopramMonitor Closely (1)arformoterol and citalopram both increase QTc interval. Use Caution/Monitor.clarithromycinMonitor Closely (1)arformoterol and clarithromycin both increase QTc interval. Use Caution/Monitor.clemastineMonitor Closely (1)clemastine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.clomipramineMonitor Closely (1)clomipramine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.Serious - Use Alternative (1)clomipramine, arformoterol. Other (see comment). Avoid or Use Alternate Drug. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.clonazepamMonitor Closely (1)clonazepam increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.clorazepateMonitor Closely (1)clorazepate increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.clozapineMonitor Closely (2)clozapine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor. arformoterol and clozapine both increase QTc interval. Use Caution/Monitor.codeineMonitor Closely (1)codeine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.crizotinibMonitor Closely (1)arformoterol and crizotinib both increase QTc interval. Use Caution/Monitor.cyclizineMonitor Closely (1)cyclizine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.cyclopenthiazideMonitor Closely (1)arformoterol and cyclopenthiazide both decrease serum potassium. Use Caution/Monitor.Minor (1)arformoterol, cyclopenthiazide. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Hypokalemia.cyproheptadineMonitor Closely (1)cyproheptadine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.dasatinibMonitor Closely (1)arformoterol and dasatinib both increase QTc interval. Use Caution/Monitor.deflazacortMonitor Closely (1)arformoterol and deflazacort both decrease serum potassium. Use Caution/Monitor.degarelixMonitor Closely (1)arformoterol and degarelix both increase QTc interval. Use Caution/Monitor.desipramineMonitor Closely (2)desipramine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor. arformoterol and desipramine both increase QTc interval. Use Caution/Monitor.Serious - Use Alternative (1)desipramine, arformoterol. Other (see comment). Avoid or Use Alternate Drug. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.deutetrabenazineMonitor Closely (1)arformoterol and deutetrabenazine both increase QTc interval. Use Caution/Monitor. At the maximum recommended dose, deutetrabenazine does not prolong QT interval to a clinically relevant extent. Certain